Valproic acid and suberoylanilide hydroxamic acid (SAHA), compounds that inhibit HDAC, can improve autophagy by modifying histone acetylation, thereby enhancing protein clearance and potentially treating neurodegenerative diseases [158]. The gene discussed is HDAC9; the disease is neurodegenerative disease.